Table of Content


Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing the Study
1.3 What’s New in This Update?
1.4 Scope of Report
1.5 Market Analyses and Forecasts
1.6 Methodology
1.7 Intended Audience
1.8 Information Sources
1.9 Analyst’s Credentials

Chapter 2 Summary and Highlights
2.1 Definitions
2.2 Applications
2.3 Research and Commercialization
2.4 Funding
2.5 Market
Chapter 3 Overview
3.1 Cells
3.2 Stem Cells
3.2.1 Induced Pluripotent Stem Cells
Chapter 4 Stem Cell Research
4.1 History
4.2 Embryonic Stem Cells
4.2.1 Growth and Identification of Embryonic Stem Cells
4.2.2 Stimulating Embryonic Stem Cells to Differentiate
4.3 Adult Stem Cells
4.3.1 Mesenchymal Stem Cells
4.3.2 Hematopoietic Stem Cells
4.3.3 Neural Stem Cell
4.3.4 Endothelial Progenitor Cell
4.3.5 Epithelial Stem Cell
4.3.6 Very Small Embryonic-Like Cell
4.4 Cord Blood Stem Cells
4.5 Induced Pluripotent Stem Cells
4.5.1 Nuclear Reprogramming
4.6 Cell-Based Therapeutics
4.6.1 Embryonic-Derived Stem Cells
4.6.2 Adult and Progenitor-Derived Stem Cells
4.6.3 Engineered Stem Cells for Transplantation
4.7 Therapeutic Stem Cell Banking
4.8 Stem Cell-Based Biomedical Research
4.9 Stem Cell Research Centers
4.10 Regulation of Stem Cell Research
4.10.1 National Regulatory Measures
4.11 Practicalities of Stem Cell Research and Production
4.11.1 Stem Cell Production
4.11.2 Stem Cell Acquisition
4.11.3 Stem Cell Production Economics
4.11.4 Customized Therapy
4.11.5 Banks
4.11.6 Novel Stem Cell Production Developments
4.11.7 Isolation and Engineering
4.11.8 Adult Stem Cells
4.11.9 Embryonic Stem Cells
4.11.10 Induced Pluripotent Stem Cells
4.11.11 Bioprinting
4.12 Stem Cell Banking
4.13 Impact of COVID-19 on Stem Cell Therapy
4.13.1 Impact of COVID-19 on iPSCs
Chapter 5 Stem Cell Applications
5.1 Regenerative Medicine
5.2 Current Stem Cell Therapy Applications
5.2.1 Cancer
Chapter 6 Stem Cell Patents
6.1 General Background on Patents
6.1.1 Stem Cell Patents
6.2 Policies by Country
6.2.1 United States
6.2.2 Canada
6.2.3 European Patent Convention
6.2.4 United Kingdom
6.2.5 Germany
6.2.6 Japan
6.2.7 China
4.3 Induced Pluripotent Stem Cells
4.4 Recent Patent Activity
4.5 Clinical Trials
Chapter 7 Stem Cell Markets
7.1 Markets for Stem Cells
7.2 Market Dynamics
7.2.1 Market Drivers
7.2.2 Market Opportunities by Therapeutic Class
7.3 Global Market Estimates and Forecasts
7.3.1 North America
7.3.2 Europe
7.3.3 Asia-Pacific
7.3.4 Rest of the World
Chapter 8 Emerging Technologies in the Market
8.1 Stem Cell Market in 2022 and Beyond
8.1.1 Oncology Applications
8.1.2 Dermatology Applications
8.1.3 Genetically Modified Stem Cells
8.1.4 Disease Modeling
8.1.5 Sustainable Meat Sources
8.1.6 Bioprinting
8.1.7 Surgery
8.1.8 COVID-19
8.2 Emerging Technologies in Stem Cell Research
Chapter 9 Company Profiles
3-D MATRIX MEDICAL TECHNOLOGY
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD.
BRAINSTORM CELL THERAPEUTICS INC.
CELYAD
CYTORI THERAPEUTICS INC.
EPISTEM LTD.
FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
GAMIDA CELL LTD.
HYBRID ORGAN GMBH
INTERNATIONAL STEM CELL CORP.
ARTERIOCYTE MEDICAL SYSTEMS INC. (ISTO BIOLOGICS)
LISATA THERAPEUTICS.
MESOBLAST LTD.
RENEURON GROUP
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS
U.S. STEM CELL INC.
VERICEL CORP.
VERASTEM INC.
VIACYTE INC.
VITRO BIOPHARMA
WICELL RESEARCH INSTITUTE
Chapter 10 Appendix: Glossary



List of Figures

List of Figures
Summary Figure : Global Stem Cell Market, by Region, 2020-2027
Figure 1 : Early Development of Embryo
Figure 2 : Funding for Stem Cell Research, 2016-2023 (Estimated)
Figure 3 : Stem Cell Therapy Application in Cancer Treatment
Figure 4 : Distribution of Clinical Trial Phases on Stem Cell Therapy, 2023

List of Tables

List of Tables
Summary Table : Global Stem Cell Market, by Region, Through 2027
Table 1 : Funding for Various Research, 2016-2023 (Estimated)
Table 2 : Bioprinting Emerging Platforms
Table 3 : Countries Engaged in the ISCBI Program
Table 4 : Patents Related to Induced Pluripotent Stem-Cells, 2021 and 2022
Table 5 : Stem Cell Patents, by Type, 2021
Table 6 : Select Clinical Trials on Stem Cell Research in 2021
Table 7 : Select Clinical Trials on Stem Cell Research in 2022
Table 8 : Select Clinical Trials on Stem Cells in January 2023
Table 9 : Clinical Trials on Various Heart Conditions, 2021-2022
Table 10 : Clinical Trials on Neurodegenerative Diseases, 2021-2022
Table 11 : Global Stem Cell Market, by Region, Through 2027
Table 12 : North American Stem Cell Market, by Country, Through 2027
Table 13 : U.S. Stem Cell Market, Through 2027
Table 14 : Canadian Stem Cell Market, Through 2027
Table 15 : Mexican Stem Cell Market, Through 2027
Table 16 : Regulatory Scenario of European Country
Table 17 : European Stem Cell Market, by Country, Through 2027
Table 18 : French Stem Cell Market, Through 2027
Table 19 : German Stem Cell Market, Through 2027
Table 20 : Italian Stem Cell Market, Through 2027
Table 21 : Spanish Stem Cell Market, Through 2027
Table 22 : U.K. Stem Cell Market, Through 2027
Table 23 : Asia-Pacific Stem Cell Policies, 2021
Table 24 : Asia-Pacific Stem Cell Market, by Country, Through 2027
Table 25 : List of Approved Human Somatic Cell-Processed Products in Japan
Table 26 : Japanese Stem Cell Market, Through 2027
Table 27 : Chinese Stem Cell Market, Through 2027
Table 28 : List of Approved Stem Cell Therapies and Clinical Trials on Stem Cell Therapies for Diseases in India
Table 29 : Cost of Stem Cell Therapy in India, U.K. and U.S.
Table 30 : Indian Stem Cell Market, Through 2027
Table 31 : Rest of the World Stem Cell Market, Through 2027